New plan could prevent university medical discoveries from making it out of the lab
The National Institutes of Health awarded over $157 million in research grants to Dartmouth, the University of New Hampshire, and other institutions across the state last year. This funding, and similar grants from other federal agencies, help researchers make groundbreaking discoveries across a host of sectors, from life sciences and agriculture to computing and energy.
Yet a new proposal from the Biden administration could prevent the most exciting university discoveries from making it out of the lab.
The plan would give federal officials unprecedented power to interfere in the contracts signed between academic research institutions and private companies. That’d discourage companies from licensing the discoveries made by these institutions, and thereby prevent firms from turning universities’ good ideas into tangible products.
Advertisement
The proposal dramatically reinterprets the government’s “march-in” rights under the Bayh-Dole Act of 1980.
Most Americans have likely never heard of that bipartisan law, which has fueled our country’s medical and technological innovation for four decades. The Bayh-Dole Act allowed universities, other research institutions and small businesses to retain the patent rights on discoveries they made with the help of federal grants.
These institutions could then license those patents to private companies willing to take on the risk of developing real-life products.
Before Congress passed that law, the government took the patent rights on discoveries stemming from federally funded research. And because the government rarely licensed those patents, few companies worked to commercialize theoretical breakthroughs into products. Without secure patent rights, they had no incentive to, as they had no way to stop competitors from piggybacking on their work and undercutting them in the marketplace.
Put another way, taxpayers’ research dollars were advancing our collective understanding of science, but we had few tangible advances to show for it.
Advertisement
Bayh-Dole changed that by incentivizing universities to partner with companies to bring those discoveries to market. Since 1980, the patent licensing — and subsequent research, development and manufacturing — enabled by the Bayh-Dole Act has directly contributed $1 trillion to the U.S. gross domestic product and supported 6.5 million jobs. The law has been especially impactful in life sciences, leading to the development of more than 200 vaccines and life-saving drugs.
One notable example of these drugs is infliximab, which originated from research at New York University School of Medicine and was later licensed and commercialized by Janssen Biotech, now part of Johnson & Johnson, in 1998. The medicine is commonly used to treat certain forms of arthritis, which affects roughly 280,000 New Hampshire residents and one in four U.S. adults nationwide.
If the Biden administration’s proposal were in place in the 1990s, this medicine might not have made it to patients, as companies would have had very little reason to risk capital on federally funded research. Why spend billions of dollars, and more than a decade, bringing a new technology to market if the government can simply snatch the patent rights as soon as it reaches the shelves?
That is, effectively, what the new plan envisions. Drugs and other technologies would once again never make it out of university laboratories, and American patients would be at the brunt of the medical drought.
New treatments for arthritis and other diseases are just around the corner. But no matter how promising the science, those prospective treatments will never reach patients if the administration gets its way.
Advertisement
Julia Moore is executive director of Rhode Island and Northern New England for the Arthritis Foundation.
CONCORD – While Republican Gov. Kelly Ayotte has said she opposes increasing highway toll rates across the state, the Senate voted Thursday to increase rates for out-of-state license plate holders.
It now goes to the House for consideration.
This would be a $1 increase for those who have out of state plates going through the tolls at Hooksett, Hampton and Bedford for out-of-state plates, a 75 cent hike for those taking Hampton’s Exit 2 and on the Spaulding turnpike at Rochester, and a 50 cent hike for those taking the exit off I-93 to Hooksett.
Advertisement
An analysis in the bill shows that this would increase toll revenue by $53.3 million in fiscal year 2027 and go up each year to generate $81.4 million a year in 2036.
Senate Bill 627 passed on a voice vote with two Republicans, Senators Regina Birdsell of Hampstead and William Gannon of Sandown opposing.
Senator Mark E. McConkey, R-Freedom, moved to take the bill off the table and offered an amendment. He said the last time there was a systemwide increase to the turnpike toll was 19 years ago.
“I am sure we could all agree the cost of operations…has continued to escalate when revenue is not rising with it,” and he noted that with an enterprise fund, the state can only spend what it takes in.
The state has just completed a 10-year highway plan and there was a $400 million shortfall in projects that could not be paid for under the current income.
Advertisement
McConkey said the measure would not increase tolls for New Hampshire drivers with a state license plate.
“Why don’t we ask our neighbors,” to pay a toll increase. “We are getting the best of all worlds,” by passing the bill, he said, including “protecting our residents” and having resources for improvements to the turnpike system.
Sen. Gannon, R-Sandown, asked McConkey if there are any studies on impacts near the border on businesses.
If implemented, McConkey said the state will be the 27th lowest in per mile cost still. McConkey said the bill would also increase from seven to 14 days the amount of time for those with NH license plates to pay for a toll adding there are other states that also have different rates for out-of-state users.
The Hampton toll cost would go from $2 to $3, while Hooksett and Bedford would rise from $1 to $2 for out-of-state plates.
Advertisement
New Hampshire currently has the lowest rate per mile among states with tolls roads. The governor said she does not support a toll increase.
“We are not going to put a burden on drivers for a toll increase,” Ayotte said. “Families are struggling.”
WILTON, N.H. (WHDH) – A woman died in a Wilton, New Hampshire, house fire Wednesday morning, according to the New Hampshire State Fire Marshal’s Office.
At 9:08 a.m., Wilton firefighters responded to Burns Hill Road after a caller said their home was filling up with smoke. When they arrived, a single-family home was on fire and they found out two people were still inside on the second floor.
A man and a woman were both taken out of the house by firefighters and taken to Elliott Hospital. The woman was pronounced dead and the man is in serious condition.
Officials have not released the name of the victim at this time.
Advertisement
At this time, investigators are looking into the cause of the fire and are trying to determine if a power outage in the area played a factor. The fire is not currently considered suspicious.
(Copyright (c) 2025 Sunbeam Television. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)
Join our Newsletter for the latest news right to your inbox
